BPMUF
Price
$54.00
Change
+$1.17 (+2.21%)
Updated
Mar 24 closing price
Capitalization
595.9M
NCNA
Price
$0.85
Change
-$0.04 (-4.44%)
Updated
Apr 3, 04:56 PM (EDT)
Capitalization
5.45M
Ad is loading...

BPMUF vs NCNA

Header iconBPMUF vs NCNA Comparison
Open Charts BPMUF vs NCNABanner chart's image
Basilea Pharmaceutica AG
Price$54.00
Change+$1.17 (+2.21%)
Volume$100
Capitalization595.9M
NuCana
Price$0.85
Change-$0.04 (-4.44%)
Volume$903
Capitalization5.45M
BPMUF vs NCNA Comparison Chart
Loading...
NCNA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BPMUF vs. NCNA commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BPMUF is a Hold and NCNA is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 04, 2025
Stock price -- (BPMUF: $54.00 vs. NCNA: $0.90)
Brand notoriety: BPMUF and NCNA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BPMUF: 77% vs. NCNA: 107%
Market capitalization -- BPMUF: $585.71M vs. NCNA: $5.45M
BPMUF [@Biotechnology] is valued at $585.71M. NCNA’s [@Biotechnology] market capitalization is $5.45M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.64B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BPMUF’s FA Score shows that 1 FA rating(s) are green whileNCNA’s FA Score has 1 green FA rating(s).

  • BPMUF’s FA Score: 1 green, 4 red.
  • NCNA’s FA Score: 1 green, 4 red.
According to our system of comparison, BPMUF is a better buy in the long-term than NCNA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NCNA’s TA Score shows that 3 TA indicator(s) are bullish.

  • NCNA’s TA Score: 3 bullish, 6 bearish.

Price Growth

BPMUF (@Biotechnology) experienced а 0.00% price change this week, while NCNA (@Biotechnology) price change was +8.45% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.57%. For the same industry, the average monthly price growth was -10.69%, and the average quarterly price growth was -14.76%.

Reported Earning Dates

NCNA is expected to report earnings on Aug 14, 2024.

Industries' Descriptions

@Biotechnology (-8.57% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BPMUF($596M) has a higher market cap than NCNA($5.45M). BPMUF YTD gains are higher at: 2.215 vs. NCNA (-24.361). BPMUF has higher annual earnings (EBITDA): -4.5M vs. NCNA (-29.33M). BPMUF has more cash in the bank: 63M vs. NCNA (11.4M). NCNA has less debt than BPMUF: NCNA (221K) vs BPMUF (112M). BPMUF has higher revenues than NCNA: BPMUF (149M) vs NCNA (0).
BPMUFNCNABPMUF / NCNA
Capitalization596M5.45M10,932%
EBITDA-4.5M-29.33M15%
Gain YTD2.215-24.361-9%
P/E Ratio51.42N/A-
Revenue149M0-
Total Cash63M11.4M553%
Total Debt112M221K50,679%
FUNDAMENTALS RATINGS
BPMUF vs NCNA: Fundamental Ratings
BPMUF
NCNA
OUTLOOK RATING
1..100
4526
VALUATION
overvalued / fair valued / undervalued
1..100
89
Overvalued
17
Undervalued
PROFIT vs RISK RATING
1..100
62100
SMR RATING
1..100
9299
PRICE GROWTH RATING
1..100
4690
P/E GROWTH RATING
1..100
28100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

NCNA's Valuation (17) in the Biotechnology industry is significantly better than the same rating for BPMUF (89) in the null industry. This means that NCNA’s stock grew significantly faster than BPMUF’s over the last 12 months.

BPMUF's Profit vs Risk Rating (62) in the null industry is somewhat better than the same rating for NCNA (100) in the Biotechnology industry. This means that BPMUF’s stock grew somewhat faster than NCNA’s over the last 12 months.

BPMUF's SMR Rating (92) in the null industry is in the same range as NCNA (99) in the Biotechnology industry. This means that BPMUF’s stock grew similarly to NCNA’s over the last 12 months.

BPMUF's Price Growth Rating (46) in the null industry is somewhat better than the same rating for NCNA (90) in the Biotechnology industry. This means that BPMUF’s stock grew somewhat faster than NCNA’s over the last 12 months.

BPMUF's P/E Growth Rating (28) in the null industry is significantly better than the same rating for NCNA (100) in the Biotechnology industry. This means that BPMUF’s stock grew significantly faster than NCNA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
NCNA
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
82%
MACD
ODDS (%)
Bullish Trend 2 days ago
86%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
77%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
89%
Advances
ODDS (%)
Bullish Trend 2 days ago
80%
Declines
ODDS (%)
Bearish Trend 14 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
82%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
NCNA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PCSVX16.02N/A
N/A
PACE Small/Medium Co Value Equity P
TRSSX23.42N/A
N/A
T. Rowe Price Instl Small-Cap Stock
HEOSX15.77N/A
N/A
Hartford Climate Opportunities R4
TAISX10.86N/A
N/A
Nuveen Quant Intl Small Cap Eq I
FTVZX33.18N/A
N/A
FullerThaler Behav Md-Cp Val R6

BPMUF and

Correlation & Price change

A.I.dvisor indicates that over the last year, BPMUF has been loosely correlated with AAVXF. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if BPMUF jumps, then AAVXF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BPMUF
1D Price
Change %
BPMUF100%
N/A
AAVXF - BPMUF
47%
Loosely correlated
N/A
ABCZF - BPMUF
38%
Loosely correlated
N/A
ALZN - BPMUF
36%
Loosely correlated
+4.51%
GTBP - BPMUF
29%
Poorly correlated
-0.42%
NCNA - BPMUF
28%
Poorly correlated
+1.13%
More